End of month update
Tough month this month from being up 40% to being down 15%. Huge swing driven mainly by NTLA.
The pause of Intellia Therapeutics’ Phase 3 MAGNITUDE trials led to a drop in share price attributed to serious adverse effects, primarily liver toxicity. Analysts have cut price targets,... Vis flere Oversett
Biotech (Intellia Therapeutics) — The “moonshot” in the mix. Biotech stayed choppy this month, and NTLA remains a catalyst-driven name where headlines can swing prices fast. Thesis unchanged: I’m holding for clinical progress and partnership momentum rather than trying to trade every wiggle. Up 40% MTD,... Vis flere Oversett
As we wrap up the month, here’s a concise check-in on the core parts of my portfolio and what I’m watching next.
UK REITs (PHP, SGRO). Rates have eased from the peak but long gilts remain elevated, so listed property is still range-bound. Within that, logistics and primary-care assets continue to show... Vis flere Oversett
As we wrap up the month, here’s a quick update on key areas of my portfolio:
UK real estate investment trusts have been treading water as the market continues to price in “higher for longer” interest rates. That said, we’re starting to see stabilisation in asset values and selective resilience in logistics... Vis flere Oversett
End of month update
With the war between Israel and Iran defused, the market is resuming its move to all-time highs and even higher. We're entering a seasonally strong period for the Nasdaq index. All eyes are once again focused on the macroeconomic picture, preparations for the reporting season... Vis flere Oversett
End of month update
A rather volatile month with the tariff announcement and shock reaction in response to that.
I am staying the course with REITs and bonds at the moment, anticipating the yields to - finally - decline. Wild swings during the month of April, but 10Y and 20Y yields finish the month... Vis flere Oversett
End of month update
Not the best month as portfolio dips and erases YTD gains
The yield on the US 10-year Treasury note fell to around 4.2% on Monday, marking its second consecutive decline as investors sought safe-haven assets amid growing concerns over the US economic outlook and the impact of escalating... Vis flere Oversett
End of month update
$PETS.L (Pets at Home Group Plc) - speculations about a potential acquisition by a private equity firm became a positive catalyst for the share price. A 5.45% dividend yield is amazing, and valuation multiplicators are attractive. Fundamentally, the number of households owning pets... Vis flere Oversett
End of month update
Bonds
In January 2025, U.S. bond investors adopted defensive strategies amid uncertainties surrounding the Trump administration's fiscal policies and the Federal Reserve's interest rate trajectory. The Fed maintained the federal funds rate at 4.25%-4.50%, with Chair Jerome... Vis flere Oversett
I am thankful to be ending this year in green.
The volatility of my investments has seen my portfolio fluctuate between -15% due to rising treasury yields in the first half of 2024, to +25% in the 2nd half fuelled by China's surge, ending the year marginally up 3%. The risk score has increased from... Vis flere Oversett
1
3
0
Bli med millioner av tradere
Finn en trader du liker og klikk på kopier. Når de trader gjør du det samme
We use our own and third-party cookies on our websites to enhance your experience, analyze traffic, and for security and marketing. For more info, see our Cookie Policy or go to Manage Settings.
Privacy Preference Center
When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
More information
Manage Consent Preferences
Strictly Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.